Viking Therapeutics Inc (VKTX) stock news · $3.97B cap
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
This VKTX news page leads with what Viking Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VKTX yet. We will not pad this page with generic market recap.
Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VKTX stock page; for the tape open the quote page.
VKTX stock news FAQ
What is VKTX's latest net income?
Latest cached Viking Therapeutics Inc (VKTX) net income was -$359.6M. Statements: https://lician.com/financials/vktx
What is VKTX's market cap?
Viking Therapeutics Inc (VKTX) market cap is $3.97B on the latest cached fundamentals snapshot.
What kind of company is VKTX?
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Where is VKTX stock news listed?
Cached stock news for Viking Therapeutics Inc (VKTX) is listed at https://lician.com/news/vktx. Filings: https://lician.com/sec/vktx
Not investment advice.